通过使用生物信息学和机器学习方法,通过PLA2G1B重组蛋白来预防癌症进展的潜在目标
Shuhong Guan1, Zhanzhan Xu2, Tingting Yang2
1Department of Respiratory and Critical Care Medicine, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou 213000, China.
International journal of biological macromolecules
|July 17, 2024
概括
脂酶A2组IB (PLA2G1B) 通过影响脂质代谢和炎症,显示出作为肺癌预防基因的潜力. 向PLA2G1B为肺癌治疗提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肺癌仍然是全球癌症相关死亡的主要原因.
- 识别新的分子标对于推进肺癌诊断和治疗至关重要.
- 脂酶A2组IB (PLA2G1B) 与脂质代谢和炎症有关,这表明它在癌症中起作用.
研究的目的:
- 为了研究PLA2G1B的分子结构,用于针对性的治疗干预.
- 确定与肺癌发展相关的关键基因和途径.
- 评估PLA2G1B作为肺癌预防性标的潜力.
主要方法:
- 对PLA2G1B的重组蛋白质结构分析.
- 使用R的STRING程序构建蛋白质-蛋白质相互作用网络.
- 应用LASSO,SVM-RFE和RF算法来识别与肺癌相关的基因.
- 基因组丰富分析 (GSEA) 探索分子途径.
主要成果:
- 设计了针对PLA2G1B结构的新型治疗策略.
- 确定了与粘附和神经活性联体受体相互作用相关的关键基因.
- 确定PLA2G1B是一种潜在的预防因素,与α-烯酸代谢密切相关.
结论:
- PLA2G1B在肺癌中发挥着重要作用,为新型疗法提供了潜在的点.
- 该研究确定了PLA2G1B作为肺癌潜在的预防基因.
- 向PLA2G1B可能会阻碍瘤生长,并为肺癌的预防和治疗提供新的途径.
关键词:
拉索·拉索 (Lasso) 是一个肺癌是一种肺癌.分子结构分子结构.在PLA2G1B中,PLA2G1B是预防 预防 预防这就是为什么RF是RF,RF是RF再组合蛋白质是一种重组蛋白质.在SVM-RFE中使用SVM-RFE.更多相关视频
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
8.9K
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.1K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K